Welcome to the 3rd ADC Payload Summit Blog
Click to explore all of our content related to the 2026 event.
Why ADC Developers Are Exploring New Payloads Beyond Topoisomerase I and Tubulin
How Technology and Development Partners Can Accelerate Next-Generation ADC Payload Innovation
Explore the Agenda
Discover the complete agenda featuring novel payload mechanisms, dual-payload ADCs, resistance biology, therapeutic index optimisation, and the industry leaders redefining ADC payload innovation.
Partner With the ADC Payload Community
Position your organization alongside 70+ senior payload, chemistry, biology, and translational R&D leaders actively seeking technologies, expertise, and collaborations to accelerate next-generation ADC development.
Join 70+ ADC Payload Leaders
Connect with scientists and decision-makers from biopharma and biotech companies tackling the industry's biggest challenges, from overcoming resistance and diversifying payloads to improving clinical translation.